Observational Study
Copyright ©The Author(s) 2016.
World J Hepatol. Dec 28, 2016; 8(36): 1623-1628
Published online Dec 28, 2016. doi: 10.4254/wjh.v8.i36.1623
Figure 1
Figure 1 Screening algorithm to detect Didanosine related liver disease in human immunodeficiency virus positive patients previously exposed to Didanosine for > 6 mo. 1ALT > upper limit normal (ULN) or platelets < lower limit normal (LLN) or TE > 7.65 kPa; 2ALT < ULN and platelets > LLN and TE < 7.65 kPa. TE: Transient elastography; HIV: Human immunodeficiency virus; DDI: Didanosine; ALT: Alanine transaminase; HBV: Hepatitis B virus; HCV: Hepatitis C virus; IQR: Interquartile range.